Navigating the Use of Cytokines to Induce Antigen-Specific Immune Tolerance
Time: 11:00 am
day: Conference Day One
Details:
• Exploring the use of IL-2 as a specific marker for CD4+ Treg production and its role in assessing ASIT induction
• Understanding the broader cytokine landscape and assessing the advantages and disadvantages of using cytokines such as IL-10, TGF-β, and IFN-γ as biomarkers of immune tolerance
• Addressing the impact of epitope spreading and bystander suppression to explore how these phenomena can influence biomarker interpretation and clinical outcomes
